About
Dr. Stéphanie Corriveau Désilets is a Hematologist focused on diagnosing and managing a spectrum of blood disorders, from anemias and clotting issues to blood cancers. Practicing at the Centre hospitalier universitaire de Sherbrooke in Sherbrooke, QC, she is part of a dedicated healthcare team committed to providing comprehensive hematology (blood disorders) care. Her practice adheres to the high standards set by the Collège des médecins du Québec (CMQ), ensuring that patients receive safe, effective, and evidence-based treatment. She addresses a wide array of benign and malignant hematologic disorders, offering both diagnostic expertise and therapeutic interventions to improve patient outcomes and quality of life.
With a Medical Degree earned in 2016, Dr. Corriveau Désilets has been practicing as a Hematologist for over 8 years. She completed extensive post-graduate medical training and certification in Hematology (Blood Disorders), equipping her with advanced knowledge and skills in this specialized field. Her dedication to continuous learning ensures she remains current with the latest developments in hematology and cancer care, providing her patients with innovative and effective treatment options.
Her clinical philosophy centers on multidisciplinary care, evidence-based treatment, and patient and family support. Dr. Corriveau Désilets is committed to fostering a compassionate, hopeful environment where patients feel empowered and well-informed about their health. She speaks French fluently and is dedicated to serving the diverse community of Sherbrooke, ensuring clear communication and personalized care for every patient she encounters.
Dr. Stéphanie Corriveau Désilets has expertise in managing a wide range of conditions, including:
Benign Hematologic (Non-Cancerous Blood) Disorders Managed
- Sickle Cell Disease & Thalassemia Syndromes: Inherited disorders affecting the structure or production of hemoglobin, leading to various complications.
- Von Willebrand Disease & Other Inherited Bleeding Disorders: Genetic conditions that impair the blood's ability to clot effectively, causing prolonged or excessive bleeding.
- Iron Deficiency Anemia: A common type of anemia caused by insufficient iron, leading to reduced red blood cell production and oxygen-carrying capacity.
Hematologic Malignancies (Blood Cancers) Treated
- Chronic Lymphocytic Leukemia (CLL) / Small Lymphocytic Lymphoma (SLL): A type of cancer that starts from white blood cells (lymphocytes) in the bone marrow, typically slow-growing.
- Acute Myeloid Leukemia (AML): A rapidly progressing cancer of the blood and bone marrow affecting myeloid cells.
- Chronic Myeloid Leukemia (CML): A type of cancer that starts in certain blood-forming cells of the bone marrow, often managed with targeted therapies.
This list provides examples of common conditions treated and is not exhaustive. Cancer and blood disorders are complex, and treatment is highly individualized. For personalized advice, please discuss your specific situation with Dr. Stéphanie Corriveau Désilets or your referring physician.
- Comprehensive Diagnosis & Management of Anemias: Investigating and treating various types of anemia, such as iron deficiency, vitamin B12/folate deficiency, hemolytic anemias (e.g., autoimmune hemolytic anemia), sickle cell disease, thalassemia, and aplastic anemia.
- Management of Bleeding Disorders (Hemophilia, Von Willebrand Disease, Platelet Function Disorders): Care for inherited and acquired conditions that affect the body's ability to form blood clots properly, including factor replacement therapies.
- Blood Product Transfusion Support & Management of Transfusion Reactions: Overseeing transfusions of red blood cells, platelets, plasma, and managing any adverse reactions.
- Performance Status Assessment & Treatment Eligibility Evaluation: Evaluating a patient's overall fitness and ability to tolerate specific anti-cancer treatments.
- Iron Overload Disorders (e.g., Hereditary Hemochromatosis) Management: Monitoring and treatment, including therapeutic phlebotomy, for conditions of excess iron storage.
- Interpretation of Special Hematologic Tests (e.g., Flow Cytometry, Cytogenetics, Molecular Studies): Analyzing results from advanced laboratory tests crucial for diagnosing and classifying hematologic conditions.
- Genetic Counseling & Testing Referrals for Hereditary Cancer Syndromes: Assessment of family history and risk factors, and coordination of referrals for genetic counseling and testing for inherited predispositions to cancer (e.g., BRCA).
Note: This list provides a general overview of services offered in Hematology (Blood Disorders). Treatment plans are highly individualized. Dr. Corriveau Désilets provides a wide array of diagnostic, therapeutic, and supportive care options tailored to each patient's specific condition and needs. Please discuss with Dr. Corriveau Désilets or your healthcare team for details relevant to your care.
All medical services and treatments are provided in accordance with the standards of practice set by the Collège des médecins du Québec (CMQ) and relevant cancer care guidelines. A referral is required.
Dr. Corriveau Désilets practices at the Centre hospitalier universitaire de Sherbrooke, located in the Fleurimont West (Hospital Area) neighbourhood of Sherbrooke. The facility is easily accessible, situated near the Carrefour de l'Estrie (Mall), with convenient access via public transit provided by the Société de transport de Sherbrooke (STS). The hospital is wheelchair accessible, ensuring ease of access for all patients. Parking is available at the facility, offering a comfortable and accessible environment for patients and visitors alike.
- Are consultations and treatments with Dr. Corriveau Désilets, an Hematologist, covered by Régie de l'assurance maladie du Québec (RAMQ) in QC?
- Medically necessary consultations, diagnostic tests (like biopsies, imaging reviews), chemotherapy, immunotherapy, targeted therapies, radiation therapy planning and delivery, and management of blood disorders by a licensed Hematologist such as Dr. Corriveau Désilets are generally covered by Régie de l'assurance maladie du Québec (RAMQ) in QC when a referral from a family doctor or another specialist is in place. Specific drug coverage for newer therapies can vary by provincial formularies and may require special authorization. It's always recommended to discuss coverage specifics with Régie de l'assurance maladie du Québec (RAMQ), Dr. Corriveau Désilets's office, the hospital's patient financial services, or the cancer care navigation services at the treatment facility.
- Do I need a referral to see Dr. Corriveau Désilets, an Hematologist?
- Yes, a referral from your family physician or another specialist is almost always required to see an Hematologist like Dr. Corriveau Désilets for assessment or treatment of cancer or significant hematological conditions. This ensures that your primary care provider is involved in your care continuum and that you are directed to the most appropriate specialist for your specific situation. Cancer care programs often have centralized intake systems that manage referrals to ensure timely access.
- How will treatment decisions be made for my condition by Dr. Corriveau Désilets?
- Treatment decisions in oncology and hematology are highly personalized and made collaboratively. Dr. Corriveau Désilets will consider many factors, including the type and stage of your cancer or blood disorder, your overall health, genetic markers of the disease (if applicable), current treatment guidelines, and importantly, your personal preferences and values. Often, cases are discussed in multidisciplinary team meetings (tumor boards) with other specialists to ensure a comprehensive approach. You will be an active participant in this decision-making process.
- How does cancer or blood disorder treatment differ for children compared to adults?
- As a Pediatric Hematologist/Oncologist, Dr. Corriveau Désilets specializes in these differences. Children's bodies react differently to treatments, and the types of cancers and blood disorders are often distinct from adult conditions. Treatment protocols are specifically designed for pediatric patients, considering their growth and development. Care is family-centered, involving parents and caregivers closely in decision-making and support.
- What happens after cancer treatment is completed with Dr. Corriveau Désilets?
- After active cancer treatment finishes, Dr. Corriveau Désilets will develop a survivorship care plan with you. This plan typically includes a schedule for follow-up appointments and tests to monitor for any signs of recurrence, management of any long-term side effects from treatment, recommendations for healthy lifestyle choices (diet, exercise), and coordination with your family doctor for ongoing general health care. The goal is to support your long-term health and well-being.
- What is targeted therapy in cancer treatment?
- Targeted therapy uses drugs or other substances to identify and attack specific types of cancer cells with less harm to normal cells. These therapies work by targeting specific genes or proteins found in cancer cells or cells related to cancer growth, like blood vessel cells. Genetic testing of the tumor is often done to see if a targeted therapy is likely to be effective. Dr. Corriveau Désilets can explain if targeted therapy is an option for your cancer.
- How is cancer care typically coordinated when seeing Dr. Corriveau Désilets?
- Cancer care and complex hematology care often involve a multidisciplinary team (MDT) of specialists working together. This team may include medical oncologists like Dr. Corriveau Désilets, surgeons, radiation oncologists, pathologists, radiologists, specialized oncology nurses, pharmacists, social workers, dietitians, genetic counselors, and palliative care specialists. Regular team meetings (often called tumor boards or MDT meetings) usually occur to discuss individual patient cases and develop comprehensive, coordinated treatment plans. Dr. Corriveau Désilets works collaboratively within this team to ensure you receive holistic and well-managed care.
- What kind of supportive care is available during cancer or hematology treatment with Dr. Corriveau Désilets?
- Supportive care is a crucial part of treatment, aiming to manage symptoms, reduce side effects, improve quality of life, and address emotional and practical needs. This can include effective pain and symptom management, nutritional support and counseling, psychological support (counseling, therapy), social work services for practical and emotional support, physiotherapy or occupational therapy, access to patient support groups, and spiritual care. Dr. Corriveau Désilets and the healthcare team at affiliated hospitals or cancer centres can connect you with these valuable resources.
Centre hospitalier universitaire de Sherbrooke
3001 12e Avenue N
Sherbrooke, QC J1H 5N4
Phone: (819) 346-1110 | Fax: (819) 564-5434
The facility is wheelchair accessible.
Dr. Corriveau Désilets is a licensed Hematologist regulated by the Collège des médecins du Québec (CMQ) under the Medical Act in QC. A referral from a family physician or other specialist is required for most consultations and treatments under the provincial health plan.
Verify registration with the Collège des médecins du Québec (CMQ): https://www.cmq.org/en/directory/physicians?number=16087